AL.com reports that a dialysis center in Bessemer, Alabama, remains shut down, but investigators have yet to identify a specific cause or pattern for the infections that killed two patients and hospitalized several others in May.
Although a laboratory analysis by the U.S. Centers for Disease Control and Prevention recovered six different bacteria from blood cultures of patients who were sickened, no pattern indicating a specific cause has been established.
The center’s ...
continue reading...
A nationwide emergency recall of baby aspirin bottles was initiated on June 17th, 2013 after a CVS pharmacist discovered one bottle had been filled with acetaminophen — otherwise known by the brand name Tylenol.
More than 16,000 bottles have voluntarily been recalled by Advance Pharmaceutical, Inc., the company responsible for the filling and labeling of the bottles. These bottles are labeled “Enteric Coated Aspirin Tablets, 81-mg.” The recall was prompted by a ...
continue reading...
A story in the Irish Independent says Pfizer intends to sell one of its Irish plants, in large part because of declining revenues from its anti-cholesterol drug Lipitor.
Sales of Lipitor, a former blockbuster for the company, have been plummeting recently because its patent expired, opening it up to competition from generics. The drug has also been the subject of some recent health concerns.
The U.S. Food and Drug Administration has added ...
continue reading...
The U.S. Food and Drug Administration is investigating whether olmesartan-based blood pressure drugs Benicar, Azor, and Tribenzor increase the risk of enteropathy.
Benicar, known as olmesartan, an angiotensin II receptor blocker, was approved by the FDA on April 25, 2002, to treat high blood pressure. It is manufactured under the brand names Benicar, Benicar HCT, Azor, and Tribenzor.
Recently, the FDA issued a safety warning that Benicar, Azor, and Tribenzor can ...
continue reading...
A story in the Huffington Post says that a Medicare program meant to provide medications for the elderly and disabled is subject to widespread abuse.
An analysis by public advocacy journalism Website ProPublica found that that healthcare professionals throughout the country are prescribing large quantities of drugs under the program that are potentially harmful or addictive, and that the federal officials charged with overseeing the program have done little to curb ...
continue reading...
An article from the Daily Report Online describes a woman in Georgia who filed the first federal claim against one of the Transvaginal mesh manufacturers. The claim against C.R. Bard detailed the health problems she’s endured as a result of receiving a vaginal mesh implant. She explains the Transvaginal mesh device was implanted to solve prior bladder problems, but it only made matters worse. She immediately sought medical help ...
